Fig. 2 | Scientific Reports

Fig. 2

From: The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen

Fig. 2

Kaplan‒Meier survival curves of PLR patients. Patients in the low PLR subgroup had worse OS (A) and PFS (B) than those in the high PLR subgroup. Low PLR was not associated with worse OS (C) but worse PFS (D) in the lower-risk MM groups (including ISS-I and ISS-II). A low PLR was associated with worse OS (E) and PFS (F) in the high-risk MM group (ISS-III).

Back to article page